CRAT Antikörper (AA 181-346) (FITC)
-
- Target Alle CRAT Antikörper anzeigen
- CRAT (Carnitine O-Acetyltransferase (CRAT))
-
Bindungsspezifität
- AA 181-346
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CRAT Antikörper ist konjugiert mit FITC
- Applikation
- Bitte anfragen
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Carnitine O-acetyltransferase protein (181-346AA)
- Isotyp
- IgG
- Top Product
- Discover our top product CRAT Primärantikörper
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- CRAT (Carnitine O-Acetyltransferase (CRAT))
- Andere Bezeichnung
- CRAT (CRAT Produkte)
- Hintergrund
-
Background: Carnitine acetylase is specific for short chain fatty acids. Carnitine acetylase seems to affect the flux through the pyruvate dehydrogenase complex. It may be involved as well in the transport of acetyl-CoA into mitochondria.
Aliases: CACP_HUMAN antibody, Carnitine acetylase antibody, Carnitine acetyltransferase antibody, Carnitine O acetyltransferase antibody, Carnitine O-acetyltransferase antibody, CAT antibody, CAT1 antibody, CrAT antibody
- UniProt
- P43155
- Pathways
- Monocarboxylic Acid Catabolic Process
-